Marks and Spencer plans to launch supermarket-size food stores

Marks and Spencer plans to launch supermarket-size food stores

Published: 22 hours ago By Pankaj Singh

The announcement ties in with a recent agreement signed by M&S with Ocado Marks and Spencer (M&S) is reportedly set to persuade families by opening super market-sized food stores to widen the range of food it offers. As per trusted....

PhaseBios Phase 1 PB2452 clinical trial results published in the NEJM

PhaseBio Biopharmaceuticals Inc., a U.S.-based clinical-stage biopharmaceutical company, has reportedly announced that results of its Phase 1 clinical trial  of PB2452, which is a new reversal agent for the anti-platelet drug ‘ti....

Tourism Malaysia & ShopBack join hands to lure travelers to the nation

In a move to facilitate growth of online travel bookings, Tourism Malaysia and ShopBack Malaysia have reportedly entered into a collaboration to support the biggest ShopBack-organized Online Travel Fair, being held in Malaysia from March 11....

HealthTrackRx™ forms JV with Marshall Health & Mountain Health Network

The newly formed organization will focus on preventing an opioid epidemic in West Virginia and its surrounding regions. Hospital & healthcare company, HealthTrackRx™ has recently entered into a joint venture (JV) with M....

Singapore Post shows signs of possible exit from U.S. ecommerce market

Reports suggest that Singapore Post (SingPost) could wind down or sell off its U.S. e-commerce business after performing a strategic review of the loss-making unit. Analysts have predicted that a divestment or closing down of the unit could....

Biocartis inks deal with Bristol-Myers Squibb for IdyllaTM MSI testing

Biocartis Group, a molecular diagnostics company based in Belgium, has reportedly signed a collaboration deal with the American pharmaceutical company, Bristol-Myers Squibb, for the IdyllaTM MSI testing with immune-oncology therapies a....

EARS unveils AM-111 Phase 3 trial outcomes in a peer-reviewed article

Auris Medical Holding AG (EARS), a Switzerland-headquartered pharmaceutical company, has reportedly announced the publication of a peer-reviewed scientific article which contains detailed outcomes of the HEALOS Phase 3 trial with AM-111. AM....

Industry Updates